These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27357602)

  • 1. Cumulative dosages of antipsychotic drugs are associated with increased mortality rate in patients with Alzheimer's dementia.
    Nielsen RE; Lolk A; Valentin JB; Andersen K
    Acta Psychiatr Scand; 2016 Oct; 134(4):314-20. PubMed ID: 27357602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Antipsychotics on Secular Mortality Trends in Patients With Alzheimer's Disease.
    Nielsen RE; Valentin JB; Lolk A; Andersen K
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29659206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic treatment effects on cardiovascular, cancer, infection, and intentional self-harm as cause of death in patients with Alzheimer's dementia.
    Nielsen RE; Lolk A; M Rodrigo-Domingo ; Valentin JB; Andersen K
    Eur Psychiatry; 2017 May; 42():14-23. PubMed ID: 28199869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity.
    Gardette V; Lapeyre-Mestre M; Coley N; Cantet C; Montastruc JL; Vellas B; Andrieu S
    Curr Alzheimer Res; 2012 Nov; 9(9):1106-16. PubMed ID: 22950915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.
    Ballard C; Hanney ML; Theodoulou M; Douglas S; McShane R; Kossakowski K; Gill R; Juszczak E; Yu LM; Jacoby R;
    Lancet Neurol; 2009 Feb; 8(2):151-7. PubMed ID: 19138567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
    Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
    J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Benzodiazepines and Antidepressants With 180-Day Mortality Among Patients With Dementia Receiving Antipsychotic Pharmacotherapy: A Nationwide Registry-Based Study.
    Nørgaard A; Jensen-Dahm C; Gasse C; Wimberley T; Hansen ES; Waldemar G
    J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32526104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-cause mortality in older adults with affective disorders and dementia under treatment with antipsychotic drugs: A matched-cohort study.
    Szmulewicz AG; Ferraris A; Rodriguez A; Cervera LC; Gonzalez ML; Man F; Angriman F; Martino D
    Psychiatry Res; 2018 Jul; 265():82-86. PubMed ID: 29702305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between prescription of conventional or atypical antipsychotic drugs and mortality in older persons with Alzheimer's disease.
    Musicco M; Palmer K; Russo A; Caltagirone C; Adorni F; Pettenati C; Bisanti L
    Dement Geriatr Cogn Disord; 2011; 31(3):218-24. PubMed ID: 21474930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
    Rossom RC; Rector TS; Lederle FA; Dysken MW
    J Am Geriatr Soc; 2010 Jun; 58(6):1027-34. PubMed ID: 20487081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Antipsychotics Augmentation in Patients with Depressive Disorder and Risk of Subsequent Dementia: A Nationwide Population-Based Cohort Study.
    Kim J; Ha TH; Kim K; Lee EM; Kim H; Kim DK; Won HH; Lewis M; Lee H; Myung W
    J Alzheimers Dis; 2021; 80(1):197-207. PubMed ID: 33523000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study.
    Liperoti R; Onder G; Landi F; Lapane KL; Mor V; Bernabei R; Gambassi G
    J Clin Psychiatry; 2009 Oct; 70(10):1340-7. PubMed ID: 19906339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy.
    Piersanti M; Capannolo M; Turchetti M; Serroni N; De Berardis D; Evangelista P; Costantini P; Orsini A; Rossi A; Maggio R
    Riv Psichiatr; 2014; 49(1):34-40. PubMed ID: 24572582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of antipsychotics is associated with lower mortality in patients with Alzheimer's disease: A nationwide population-based nested case-control study in Taiwan.
    Chu CS; Li WR; Huang KL; Su PY; Lin CH; Lan TH
    J Psychopharmacol; 2018 Nov; 32(11):1182-1190. PubMed ID: 29926765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    J Alzheimers Dis; 2014; 41(4):1223-8. PubMed ID: 24787914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study.
    Langballe EM; Engdahl B; Nordeng H; Ballard C; Aarsland D; Selbæk G
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):321-31. PubMed ID: 24016844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry.
    Garcia-Ptacek S; Farahmand B; Kåreholt I; Religa D; Cuadrado ML; Eriksdotter M
    J Alzheimers Dis; 2014; 41(2):467-77. PubMed ID: 24625796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality risk in current and new antipsychotic Alzheimer's disease users: Large scale Japanese study.
    Arai H; Nakamura Y; Taguchi M; Kobayashi H; Yamauchi K; Schneider LS;
    Alzheimers Dement; 2016 Jul; 12(7):823-30. PubMed ID: 27106669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.
    Livingston G; Walker AE; Katona CL; Cooper C
    J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):25-9. PubMed ID: 16801350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.